awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40889826-3FE1CD63-43D1-48EC-9286-C6918C442749
Q40889826-3FE1CD63-43D1-48EC-9286-C6918C442749
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40889826-3FE1CD63-43D1-48EC-9286-C6918C442749
Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.
P2860
Q40889826-3FE1CD63-43D1-48EC-9286-C6918C442749
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40889826-3FE1CD63-43D1-48EC-9286-C6918C442749
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b8e559535540ff7cd79dfdca90f8d8a8656fec8
P2860
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.